rhone poulenc pharma inc said plans spend mln dlrs over next five years for research and development canada said investment depends upon passage federal government bill which proposes greater protection for holders drug patents company said will spend mln dlrs upgrade its montreal operations said new patent law would drug companies reasonable protection from generic drug copying new compounds reuter 